01-02-2022 | Research Article
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
Published in: Frontiers of Medicine | Issue 1/2022
Login to get access